Machine Learning Platform to Discover Novel Growth Inhibitors of Neisseria gonorrhoeae.


Journal

Pharmaceutical research
ISSN: 1573-904X
Titre abrégé: Pharm Res
Pays: United States
ID NLM: 8406521

Informations de publication

Date de publication:
13 Jul 2020
Historique:
received: 03 04 2020
accepted: 06 07 2020
entrez: 15 7 2020
pubmed: 15 7 2020
medline: 23 4 2021
Statut: epublish

Résumé

To advance fundamental biological and translational research with the bacterium Neisseria gonorrhoeae through the prediction of novel small molecule growth inhibitors via naïve Bayesian modeling methodology. Inspection and curation of data from the publicly available ChEMBL web site for small molecule growth inhibition data of the bacterium Neisseria gonorrhoeae resulted in a training set for the construction of machine learning models. A naïve Bayesian model for bacterial growth inhibition was utilized in a workflow to predict novel antibacterial agents against this bacterium of global health relevance from a commercial library of >10 Specifically, two small molecules were found that exhibited promising activity profiles and represent novel chemotypes for agents against N. gonorrrhoeae. This represents, to the best of our knowledge, the first machine learning approach to successfully predict novel growth inhibitors of this bacterium. To assist the chemical tool and drug discovery fields, we have made our curated training set available as part of the Supplementary Material and the Bayesian model is accessible via the web. Graphical Abstract.

Identifiants

pubmed: 32661900
doi: 10.1007/s11095-020-02876-y
pii: 10.1007/s11095-020-02876-y
pmc: PMC8274436
mid: NIHMS1715097
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

141

Subventions

Organisme : NIH/NIGMS
ID : R44GM122196
Organisme : NIGMS NIH HHS
ID : R43 GM122196
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI109713
Pays : United States
Organisme : NIGMS NIH HHS
ID : R44 GM122196
Pays : United States
Organisme : NIH/NIAID
ID : U19AI109713

Références

Lancet. 1998;351 Suppl 3:8-11
pubmed: 9652713
PLoS One. 2018 Jan 12;13(1):e0189538
pubmed: 29329334
Antimicrob Agents Chemother. 2009 Sep;53(9):3744-51
pubmed: 19528266
Curr Opin Infect Dis. 2018 Jun;31(3):246-250
pubmed: 29601324
Chemosphere. 2011 Mar;82(11):1636-43
pubmed: 21145574
J Chem Inf Model. 2015 Jun 22;55(6):1231-45
pubmed: 25994950
Sex Transm Dis. 2019 Mar;46(3):e18-e25
pubmed: 30363025
J Chem Inf Model. 2015 May 26;55(5):956-62
pubmed: 25915687
Nat Rev Microbiol. 2018 Apr;16(4):226-240
pubmed: 29430011
J Antimicrob Chemother. 2018 Aug 1;73(8):2064-2071
pubmed: 29726994
PLoS One. 2013 May 07;8(5):e63240
pubmed: 23667592
BMC Microbiol. 2005 Apr 27;5:21
pubmed: 15857514
J Infect Dis. 2018 Jul 24;218(5):801-808
pubmed: 29701830
Nat Protoc. 2008;3(2):163-75
pubmed: 18274517
J Chem Inf Model. 2013 Nov 25;53(11):3054-63
pubmed: 24144044
mBio. 2018 Dec 18;9(6):
pubmed: 30563908
ACS Med Chem Lett. 2017 Sep 14;8(10):1099-1104
pubmed: 29057058
PLoS Med. 2017 Jul 7;14(7):e1002344
pubmed: 28686231
J Glob Antimicrob Resist. 2019 Jun;17:3-7
pubmed: 30448519
Biochim Biophys Acta. 1975 Oct 20;405(2):442-51
pubmed: 1180967
Drug Discov Today. 2006 Dec;11(23-24):1046-53
pubmed: 17129822
Microbiology (Reading). 1995 Mar;141 ( Pt 3):611-22
pubmed: 7711899
Mol Cell Biochem. 2008 Sep;316(1-2):71-85
pubmed: 18563535
J Comput Aided Mol Des. 2018 Feb;32(2):363-374
pubmed: 29264790
J Chem Inf Model. 2016 Feb 22;56(2):275-85
pubmed: 26750305
J Med Chem. 2002 Apr 11;45(8):1712-22
pubmed: 11931626
Bioorg Med Chem. 2014 Jul 15;22(14):3713-9
pubmed: 24890653
Pharm Res. 2018 Jun 29;35(9):170
pubmed: 29959603
Nat Chem Biol. 2016 Dec;12(12):1004-1006
pubmed: 27748750
Methods Mol Biol. 2013;993:245-62
pubmed: 23568475
ACS Infect Dis. 2019 Dec 13;5(12):2148-2163
pubmed: 31625383
Mol Pharm. 2017 Dec 4;14(12):4462-4475
pubmed: 29096442
Nucleic Acids Res. 2012 Jan;40(Database issue):D1100-7
pubmed: 21948594
Antimicrob Agents Chemother. 2015 Mar;59(3):1605-11
pubmed: 25547354
J Clin Microbiol. 2005 Sep;43(9):4321-7
pubmed: 16145072
Cell Chem Biol. 2020 Feb 20;27(2):172-185.e11
pubmed: 31711854
Euro Surveill. 2013 Apr 04;18(14):20444
pubmed: 23594520
Cell Chem Biol. 2020 May 21;27(5):560-570.e10
pubmed: 32197094
Chem Biol. 2013 Mar 21;20(3):370-8
pubmed: 23521795
J Chem Inf Model. 2010 May 24;50(5):742-54
pubmed: 20426451
Pharm Res. 2016 Feb;33(2):433-49
pubmed: 26415647
J Med Chem. 2002 Nov 21;45(24):5311-20
pubmed: 12431058
Antimicrob Agents Chemother. 2018 Feb 23;62(3):
pubmed: 29311070
Mol Pharm. 2018 Oct 1;15(10):4346-4360
pubmed: 29672063
J Med Chem. 2012 Jan 26;55(2):743-53
pubmed: 22077389
J Chem Inf Model. 2015 Jun 22;55(6):1246-60
pubmed: 25995041

Auteurs

Janaina Cruz Pereira (JC)

Department of Pharmacology, Physiology, and Neuroscience, Rutgers University New Jersey Medical School, I-503 185 South Orange Avenue, Newark, NJ, 07103, USA.

Samer S Daher (SS)

Department of Pharmacology, Physiology, and Neuroscience, Rutgers University New Jersey Medical School, I-503 185 South Orange Avenue, Newark, NJ, 07103, USA.

Kimberley M Zorn (KM)

Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, NC, 27606, USA.

Matthew Sherwood (M)

Department of Pharmacology, Physiology, and Neuroscience, Rutgers University New Jersey Medical School, I-503 185 South Orange Avenue, Newark, NJ, 07103, USA.

Riccardo Russo (R)

Division of Infectious Disease, Department of Medicine and the Ruy V. Lourenço Center for the Study of Emerging and Re-emerging Pathogens, Rutgers University New Jersey Medical School, I-503 185 South Orange Avenue, Newark, NJ, 07103, USA.

Alexander L Perryman (AL)

Department of Pharmacology, Physiology, and Neuroscience, Rutgers University New Jersey Medical School, I-503 185 South Orange Avenue, Newark, NJ, 07103, USA.
Repare Therapeutics,, 7210 Rue Frederick-Banting Suite 100, Montreal, QC, H4S 2A1, Canada.

Xin Wang (X)

Department of Pharmacology, Physiology, and Neuroscience, Rutgers University New Jersey Medical School, I-503 185 South Orange Avenue, Newark, NJ, 07103, USA.
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Madeleine J Freundlich (MJ)

Stuart Country Day School of the Sacred Heart, 1200 Stuart Road, Princeton, NJ, 08540, USA.

Sean Ekins (S)

Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, NC, 27606, USA.
Collaborations in Chemistry, Inc. 5616 Hilltop Needmore Road, Fuquay-, Varina, NC, 27526, USA.

Joel S Freundlich (JS)

Department of Pharmacology, Physiology, and Neuroscience, Rutgers University New Jersey Medical School, I-503 185 South Orange Avenue, Newark, NJ, 07103, USA. freundjs@rutgers.edu.
Division of Infectious Disease, Department of Medicine and the Ruy V. Lourenço Center for the Study of Emerging and Re-emerging Pathogens, Rutgers University New Jersey Medical School, I-503 185 South Orange Avenue, Newark, NJ, 07103, USA. freundjs@rutgers.edu.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents

Exploring blood-brain barrier passage using atomic weighted vector and machine learning.

Yoan Martínez-López, Paulina Phoobane, Yanaima Jauriga et al.
1.00
Blood-Brain Barrier Machine Learning Humans Support Vector Machine Software

Understanding the role of machine learning in predicting progression of osteoarthritis.

Simone Castagno, Benjamin Gompels, Estelle Strangmark et al.
1.00
Humans Disease Progression Machine Learning Osteoarthritis

Classifications MeSH